484 related articles for article (PubMed ID: 17697898)
1. Hypertriglyceridemia and cardiovascular risk reduction.
Jacobson TA; Miller M; Schaefer EJ
Clin Ther; 2007 May; 29(5):763-777. PubMed ID: 17697898
[TBL] [Abstract][Full Text] [Related]
2. Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin.
Breuer HW
Curr Med Res Opin; 2001; 17(1):60-73. PubMed ID: 11464448
[TBL] [Abstract][Full Text] [Related]
3. Optimal management of combined dyslipidemia: what have we behind statins monotherapy?
Tenenbaum A; Fisman EZ; Motro M; Adler Y
Adv Cardiol; 2008; 45():127-153. PubMed ID: 18230960
[TBL] [Abstract][Full Text] [Related]
4. Hypertriglyceridemia-why, when and how should it be treated?
Gouni-Berthold I; Krone W
Z Kardiol; 2005 Nov; 94(11):731-9. PubMed ID: 16258774
[TBL] [Abstract][Full Text] [Related]
5. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
Cziraky MJ; Watson KE; Talbert RL
J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
[TBL] [Abstract][Full Text] [Related]
6. Long-chain omega-3 fatty acids, fibrates and niacin as therapeutic options in the treatment of hypertriglyceridemia: a review of the literature.
Ito MK
Atherosclerosis; 2015 Oct; 242(2):647-56. PubMed ID: 26296750
[TBL] [Abstract][Full Text] [Related]
7. Treatment of hypertriglyceridemia: a review of current options.
Vrablík M; Češka R
Physiol Res; 2015; 64(Suppl 3):S331-40. PubMed ID: 26680666
[TBL] [Abstract][Full Text] [Related]
8. TRIGLYCERIDES, ATHEROSCLEROSIS, AND CARDIOVASCULAR OUTCOME STUDIES: FOCUS ON OMEGA-3 FATTY ACIDS.
Handelsman Y; Shapiro MD
Endocr Pract; 2017 Jan; 23(1):100-112. PubMed ID: 27819772
[TBL] [Abstract][Full Text] [Related]
9. Hypertriglyceridemia: the importance of identifying patients at risk.
Kushner PA; Cobble ME
Postgrad Med; 2016 Nov; 128(8):848-858. PubMed ID: 27710158
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological management of high triglycerides and low high-density lipoprotein cholesterol.
Szapary PO; Rader DJ
Curr Opin Pharmacol; 2001 Apr; 1(2):113-20. PubMed ID: 11714084
[TBL] [Abstract][Full Text] [Related]
11. Triglyceride-lowering therapies reduce cardiovascular disease event risk in subjects with hypertriglyceridemia.
Maki KC; Guyton JR; Orringer CE; Hamilton-Craig I; Alexander DD; Davidson MH
J Clin Lipidol; 2016; 10(4):905-914. PubMed ID: 27578122
[TBL] [Abstract][Full Text] [Related]
12. Is hypertriglyceridemia atherogenic?
Roubille F; Sultan A; Huet F; Leclercq F; Macia JC; Gervasoni R; Delseny D; Akodad M; Roubille C
Presse Med; 2018 Sep; 47(9):757-763. PubMed ID: 30262206
[TBL] [Abstract][Full Text] [Related]
13. Niacin and fibrate use among patients with high triglycerides and low high-density lipoprotein cholesterol.
Toth PP; Zarotsky V; Sullivan JM; Laitinen D
Curr Med Res Opin; 2009 Jun; 25(6):1355-63. PubMed ID: 19425901
[TBL] [Abstract][Full Text] [Related]
14. Hypertriglyceridemia and cardiovascular disease management.
Codario RA
J Am Acad Nurse Pract; 2007; 19(12 Suppl 2):7-10, 13-4. PubMed ID: 18510282
[No Abstract] [Full Text] [Related]
15. Hypertriglyceridemia: management of atherogenic dyslipidemia.
Bersot T; Haffner S; Harris WS; Kellick KA; Morris CM
J Fam Pract; 2006 Jul; 55(7):S1-8. PubMed ID: 16822443
[TBL] [Abstract][Full Text] [Related]
16. Treating hypertriglyceridemia.
Holub BJ
CMAJ; 2007 Sep; 177(6):604; author reply 604-5. PubMed ID: 17846446
[No Abstract] [Full Text] [Related]
17. Treatment options for the management of hypertriglyceridemia: strategies based on the best-available evidence.
Maki KC; Bays HE; Dicklin MR
J Clin Lipidol; 2012; 6(5):413-26. PubMed ID: 23009777
[TBL] [Abstract][Full Text] [Related]
18. Statins, fibrates, nicotinic acid, cholesterol absorption inhibitors, anion-exchange resins, omega-3 fatty acids: which drugs for which patients?
Drexel H
Fundam Clin Pharmacol; 2009 Dec; 23(6):687-92. PubMed ID: 19682084
[TBL] [Abstract][Full Text] [Related]
19. Management of hypertriglyceridemia.
Oh RC; Lanier JB
Am Fam Physician; 2007 May; 75(9):1365-71. PubMed ID: 17508532
[TBL] [Abstract][Full Text] [Related]
20. Understanding hypertriglyceridemia in women: clinical impact and management with prescription omega-3-acid ethyl esters.
Dayspring TD
Int J Womens Health; 2011 Mar; 3():87-97. PubMed ID: 21445284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
